作者:2017-07-03浏覽次數:14072

徐 标

博士研究生導師簡介

姓名

徐标

研究方向:心血管疾病的損傷和修複、心血管疾病介入治療

聯系方式

13505193257

學術兼職:

國際心髒研究協會委員

美國心髒病學會委員(FACC

美國心血管造影和介入學會委員(FSCAI

中國醫師協會整合心血管病學會副主任委員

中國醫療保健國際交流促進會心血管病分會常務委員

中國高血壓聯盟常務委員

海峽兩岸醫藥衛生交流協會心血管專業委員會常務委員

中華醫學會實用介入技術推廣培訓中心副主任委員

中華醫學會心血管病學分會委員

中國醫師協會心血管病分會精準醫學分會副主任委員

中華醫學會心血管病學分代謝學組副組長

中國老年醫學學會心血管病分會委員

江蘇省醫學會心血管病學分會主任委員

江蘇省醫師協會心血管内科醫師分會候任會長

江蘇省預防醫學會心血管疾病預防與控制專業委員會主任委員

個人簡介

FACCFSCAI,主任醫師、教授、博士生導師,心血管内科行政主任。江蘇省醫學重點人才,享受國家政府特殊津貼,中國醫師協會整合心血管病學會副主任委員,中華醫學會心血管病學分會委員,中國醫師協會心血管病分會精準醫學分會副主任委員,江蘇省醫學會心血管病學分會主任委員,江蘇省醫師協會心血管内科醫師分會候任會長,江蘇省預防醫學會心血管疾病預防與控制專業委員會主任委員等,CirculationCirculation ResearchJ hypertensionATVBIJBMSCI期刊的特約審稿人,兼任《中華高血壓雜志》、《中國動脈硬化雜志》等編委。先後主持國家自然科學基金項目研究8項,省級科研項目20餘項。發表論文300餘篇,SCI收錄150篇以上,其中兩篇發表在《Circulation》雜志上,影響因子達29.69,還有二篇論文發表在《Ann Inter Med》,影響因子25.391,兩篇發表在《BasicRes Cardio》,影響因子17.1分,研究成果被ESCACCAHA等國際著名指南引用。其帶領的團隊曾獲得其帶領的團隊曾獲得“江蘇省醫學重點學科”稱号、“江蘇省科技創新團隊”稱号、中華醫學科技三等獎、中國傑出心血管病研究獎、江蘇醫學科技一等獎、江蘇省新技術引進一等獎、江蘇省科技進步二等獎、江蘇省科技進步三等獎、南京市科技進步二等獎等多個獎項。


代表性論文[5年通訊作者和第一作者]

  1. Wei Z, Yang Y, Li Q, Yin Y, Wei Z, Zhang W, Mu D, Ni J, Sun X, Xu B. The transcriptome of circulating cells indicates potential biomarkers and therapeutic targets in the course of hypertension-related myocardial infarction. Genes Dis, 2021, 8 (4): 555-68.

  2. Wei Z, Chen Z, Zhao Y, Fan F, Xiong W, Song S, Yin Y, Hu J, Yang K, Yang L, Xu B, Ge J. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials, 2021, 275: 121000.

  3. Liu Y, Xu J, Wu M, Xu B, Kang L. Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity. Lipids Health Dis, 2021, 20 (1): 5.

  4. Liu Y, Wu M, Xu J, Xu B, Kang L. Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic mice. Eur J Pharm Sci, 2021, 161: 105788.

  5. Huang Y, Lei D, Chen Z, Xu B. Factors associated with microvascular occlusion in patients with ST elevation myocardial infarction after primary percutaneous coronary intervention. J Int Med Res, 2021, 49 (6): 3000605211024490.

  6. Hu T, Zhu P, Liu Y, Zhu H, Geng J, Wang B, Yuan G, Peng Y, Xu B. PM2.5 induces endothelial dysfunction via activating NLRP3 inflammasome. Environ Toxicol, 2021.

  7. Liu Y, Zhang W, Hu T, Ni J, Xu B, Huang W. A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo. J Vis Exp, 2020.

  8. Liu Y, Xu J, Wu M, Kang L, Xu B. The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction. J Cell Physiol, 2020, 235 (12): 8996-9004.

  9. Liu Y, Xu J, Gu R, Li Z, Wang K, Qi Y, Sun X, Xie J, Wang L, Xu B, Kang L. Circulating exosomal miR-144-3p inhibits the mobilization of endothelial progenitor cells post myocardial infarction via regulating the MMP9 pathway. Aging (Albany NY), 2020, 12 (16): 16294-303.

  10. Xuan SunZilun WeiYuyu LiJunzhuo WangJiaxin HuYong YinJun XieBiao Xu .Renal denervation restrains the inf ammatory response in myocardial ischemia–reperfusion injury. Basic Research In Cardiology(2020) 115:15.

  11. Junzhuo WangZiwei ChenQing DaiJinxuan ZhaoZilun WeiJiaxin HuXuan SunJun XieBiao Xu.Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury. Basic Research In Cardiology(2020) 115:40.

  12. Xin-Lin Zhang,Xiao-Wen Zhang, Rong-Fang Lan, Zheng Chen, Lian Wang, Wei Xu, and Biao Xu.Long-term and Temporal Outcomes of Transcatheter Versus Surgical Aortic-valve Replacement in Severe Aortic Stenosis: A Meta-analysis. Annals of Surgery.2020 Jun 3.

  13. Zilun Wei, Yining Yang ,Qiaoling Li, Yong YinZhonghai Wei, Wenfeng Zhang, Dan Mu,Jie NiXuan Sun,Biao Xu.The transcriptome of circulating cells indicates potential biomarkers and therapeutic targets in the course of hypertension-related myocardial infarction. Genes & Diseases2020

  14. Jinxuan Zhao, Xueling Li, Jiaxin Hu, Fu Chen, Shuaihua Qiao, Xuan SunLing Gao, Jun Xie, and Biao Xu Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res.2019;115(7):1205-1216

  15. Hai Cheng,, Yuhan Chen, Xueling Li, Fu Chen, Jinxuan Zhao,Jiaxin Hu, Anqi Shan, Shuaihua Qiao,Zilun Wei, Guixin He and Biao Xu. Involvement of Apelin/APJ Axis in Thrombogenesis in Value Heart Disease Patient with Atrial Fibrillation. International Heart Journal. 2019,60(1):145-150

  16. Wei Zilun, Qiao Shuaihua, Zhao Jinxuan, Liu Yihai, Li Qiaoling, Wei Zhonghai,Dai Qing, Kang Lina, Xu Biao.miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury. Life Sciences. 2019 Sep 1;232:116632.

  17. Zhong-Hai WEI, Wen-Zhi SHEN, Jian BAI, Jun XIE, Wen-Qing JI, Lian WANG, Wei XU,Biao XU.Treatment of refractory ventricular tachycardia with combination of alcohol ablation and radiofrequency ablation. Journal of Geriatric Cardiology. 2019(16):660-662.

  18. Xin-Lin Zhang , Rong-Fang Lan,Xiao-Wen Zhang, Wei Xu ,Lian Wang , Li-Na Kang,Biao Xu.Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2019;8:e012428.

  19. Xinlin ZhangTingyu WangRongfang Lan , Qing Dai , Lina Kang , Lian Wang , Yong Wang , Wei Xu , Biao Xu .Meta-Analysis Comparing Results of Transcatheter Versus Surgical Aortic-Valve Replacement in Patients WithSevereAortic Stenosis. Am J Cardiol. 00:1−10

  20. Xueling LiJinxuan ZhaoJin GengFu Chen , Zilun Wei , Chen Liu , Xinlin Zhang , Qiaoling Li , Jingmei Zhang , Ling GaoJun XieBiao Xu .Long non-coding RNA MEG3 knockdown attenuates endoplasmic reticulum stress-mediated apoptosis by targeting p53 following myocardial infarction. J Cell Mol Med. 2019 Dec;23(12):8369-8380.

  21. Zhong-Hai WeiWen-Zhi Shen , Jian Bai , Jun XieWen-Qing Ji , Lian Wang , Wei Xu , Biao Xu. Treatment of refractory ventricular tachycardia with combination of alcohol ablation and radiofrequency ablation. J Geriatr Cardiol.. 2019 Aug;16(8):660-662.

  22. Jin GengHaiyun Liu , Peibing Ge , Tingting HuYanchun ZhangXiwen ZhangBiao Xu , Bingjian WangJun Xie . PM2.5 promotes plaque vulnerability at different stages of atherosclerosis and the formation of foam cells via TLR4/MyD88/NFκB pathway. Ecotoxicol Environ Saf. 2019 Jul 30;176:76-84.

  23. Qinhua ChenRyan C GimpleGuannan LiJianzhou ChenHan WuRan LiJun XieBiao Xu .LIM kinase 1 acts as a profibrotic mediator in permanent atrial fibrillation patients with valvular heart disease. J Biosci. 2019 Mar;44(1). pii: 16.

  24. Kun WangJingmei Zhang , Ning Zhang , Yu ShenLian WangRong GuBiao XuYong Ji  Combined Primary PCI with Multiple Thrombus Burden Reduction Therapy Improved Cardiac Function in Patients with Acute Anterior Myocardial Infarction. Int Heart J. 2019 Jan 25;60(1):27-36.

  25. Zilun WeiYihai LiuShuaihua QiaoXueling Li , Qiaoling Li , Jinxuan Zhao , Jiaxin Hu , Zhonghai WeiAnqi Shan , Xuan Sun , Biao Xu . Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases. Oncology Letters. 2019;17(6):5409-5418.

  26. Han WuZheng ChenJian-Zhou ChenJun Xie, and Biao Xu.Resveratrol Improves Tube Formation in AGE-Induced Late Endothelial Progenitor Cells by Suppressing Syndecan-4 Shedding. Oxid Med Cell Longev. 2018; 2018: 9045976.

  27. Jun X, Jin G, Fu C, Jinxuan Z, Xuelin L, Jiaxin H, Shuaihua Q, Anqi S, Jianzhou C, Lian Z, Xiwen Z, Baoli Z, Biao X.PM2.5 promotes abdominal aortic aneurysm formation in angiotensin Ⅱ-infused apoe-/- mice. Biomed Pharmacother. 2018 Aug;104:550-557. 

  28. Wei ZH, Dai Q, Wu H, Song J, Wang L, Xu B.Takotsubo cardiomyopathy after pacemaker implantation. J Geriatr Cardiol. 2018 Mar;15(3):246-248.

  29. Wang K, Shen Y, Li PW, Gu R, Zhang JM, Wang L, Bai J, Xu B. ST-Segment Elevation Myocardial Infarction Patients Complicated by Out-of-Hospital Cardiac Arrest May Not Benefit from Emergency Percutaneous Intervention. Chin Med J (Engl). 2018 Mar 20;131(6):746-747.

  30. Zhang XL, Kang LN, Wang L, Xu B.Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.BMC Cardiovasc Disord. 2018 Mar 2;18(1):45.

  31. Zhang XW, Zhang XL, Xu B, Kang LN.Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials.Acta Diabetol. 2018 May;55(5):429-441.

  32. Hu L, Yao X, Huang H, Guo Z, Cheng X, Xu Y, Shen Y, Xu B, Li D.Clinical significance of germline copy number variation in susceptibility of human diseases.J Genet Genomics. 2018 Jan 20;45(1):3-12.

  33. Di W, Lv J, Jiang S, Lu C, Yang Z, Ma Z, Hu W, Yang Y, Xu B.PGC-1: The Energetic Regulator in Cardiac Metabolism.Curr Issues Mol Biol. 2018 Feb 1;28:29-46.

  34. Qing Dai, Jie Song, Jian He, Biao Xu.Rare Case of Anomalous Original Left Circumflex Artery Stenosis After Artificial Mitral Valve Replacement. JACC: Cardiovascular Interventions. 2017 Apr 10;10(7):e71-e73.

  35.  Xin-Lin Zhang, Qing-Qing Zhu, Jing-Jing Yang, Yu-Han Chen, Yang Li, Su-Hui Zhu, Jun Xie, Lian Wang,Li-Na Kang and Biao Xu.Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis. BMC Medicine.2017 Apr 21;15(1):84.

  36.  Xinlin Zhang, Jun Xie, Suhui Zhu, Yuhan Chen, Lian Wang, Biao Xu.Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy. Medicine. 96(24): p. e7010.

  37.  Xin-Lin Zhang, Qing-Qing Zhu, Li-Na Kang, Xue-Ling Li, and Biao Xu.Mid- and Long-Term Outcome Comparisons of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis. Annals of Internal Medicine. 20171679):642-654.

  38.  Xin-Lin Zhang, Biao Xu.Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement. Annals of Internal Medicine. 20171668):605.

  39. Guannan Li, Jun Xie, Jianzhou Chen, Ran Li, Han Wu, Xinlin Zhang, Qinhua Chen, Rong Gu , Biao Xu.Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload. Cardiovascular Pathology. May-June2017 Volume 28Pages74–79.

  40. Guannan Li, Jianzhou Chen, Xinlin Zhang, Guixin He, Wei Tan, Han Wu, Ran Li,Yuhan Chen, Rong Gu, Jun Xie & Biao Xu.Cardiac repair in a mouse model of acute myocardial infarction with trophoblast stem cells. Scientific Reports. 2017 Mar 15;7:44376.

  41.  Jun Xie, Yuhan Chen, Chuanxian Hu, Quanhua Pan, Bingjian Wang, Xueling Li, Jin Gengand Biao Xu.Premature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation. Oncotarget. 2017, 8(35)57981-57990.

  42. Xueling Li, Jin Geng, Yuhan Chen, Fu Chen, Chen Liu, Qiwen Xu, Jinxuan Zhao,Jiaxin Hu, Jun Xie, Biao Xu.Exposure to particulate matter induces cardiomyocytes apoptosis after myocardial infarction through NFkB activation. Biochem Biophys Res Commun. 2017 Jun 17;488(1):224-231.

  43.  Jun Xie, Suhui Zhu, Qing Dai, Jianrong Lu, Jianzhou Chen, Guannan Li, Han Wu, Ran Li, Wei Huang, Biao Xu, Wei Xu,.Oncostatin M was associated with thrombosis in patients with atrial fibrillation. Medicine. (2017) 96:18(e6806)

  44.  Gui-xin He,Jun XieHao,JiangWeiTan,Biao Xu.Effects of Qishen Yiqi Dripping Pills () in reducing myocardial injury and preserving microvascular function in patients undergoing elective percutaneous coronary intervention: A pilot randomized study. Chin J Integr Med.2017 May 3.

  45.  Wen Lu,Jun Xie, Rong Gu,and Biao Xu.Expression of integrin-linked kinase improves cardiac function in a swine model of myocardial infarction. Exp Ther Med. 2017 May;13(5):1868-1874

  46.  Jin Geng, Yanchun Zhang, Bingjian Wang, Jun Xie, Biao Xu, Ju Li.Glycosylated hemoglobin levels and clinical outcomes in nondiabetic patients with coronary artery disease. Medicine (Baltimore). 2017 Apr; 96(17): e6784.

  47.  Yang Li, Jing-Jing Yang, Su-Hui Zhu, Biao Xu, Lian Wang.Long-term efficacy and safety of carotid artery stenting versus endarterectomy: A meta analysis of randomized controlled trials. PLOS ONE. 2017 Jul 14;12(7):e0180804.

  48.  Jun Xie,Ran Li,Han Wu,Jian-Zhou Chen,Guan-Nan  Li,Qin-Hua Chen,Zhong-Hai Wei,Gui-Xin He,Lian Wang,Albett Ferro,Biao Xu. Advanced Glycation Endproducts Impair Endothelial Progenitor Cell Migration and Homing via Syndecan 4 Shedding. Stem Cells. 2017,352:522-531.

  49.  Xin-Lin Zhang, Biao Xu.Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents. Annals of Internal Medicine. 2016 Dec 6;165(11):829. doi: 10.7326/L16-0419.

  50.  Jiang C, Zhu W, Yan X, Shao Q, Xu B, Zhang M, Gong R.Rescue therapy with Tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3β. Sci Rep. 2016 Nov 18;6:36698. doi: 10.1038/srep36698.

  51.  HanWu, Zheng Chen, Jun Xie, Li-Na Kang, LianWang, and Biao Xu.High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications. Mediators Inflamm. olume 2016, Article ID 3896147, 11 pages.

  52.  Han Wu,Zhen-Qiang Sheng,Jun Xie,Ran Li,Liang Chen,Guan-Nan Li,LianWang,and Biao Xu.Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus. Oxid Med Cell Longev. Volume 2016, Article ID 9836860, 10 pages.

  53.  Zhonghai Wei,Jun Xie,Kun Wang,Lina Kang , Qing Dai ,Jian Bai, Biao Xu .Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Aged Patients With Unprotected Left Main Artery Lesions.. International Heart Journal. 2016,57(6):682-688.

  54.  Li L, Lopes J, Zhou JY, Xu B. Integrating Medical Simulation Into the Physician Assistant Physiology Curriculum. J Physician Assist Educ. 2016 Dec;27(4):156-161.

  55.  Ran Li,Han Wu ,Jun Xie ,Guannan Li ,Rong Gu ,Lina Kang ,Lian Wang,Biao Xu.Syndecan-4 regulates the bFGF-induced chemotactic migration of endothelial cells. J Mol Histol. 2016 Oct;47(5):503-9. doi: 10.1007/s10735-016-9693-0.

  56.  Li SN, Zhang XL, Cai GL, Lin RW, Jiang H, Chen JZ, Xu B,Huang W.Prognostic Significance of Frontal QRS-T Angle in Patients with Idiopathic Dilated Cardiomyopathy. Chin Med J (Engl). 2016 Aug 20;129(16):1904-11. doi: 10.4103/0366-6999.187844.

  57.  24. Zhonghai Wei, Jie Song, Xuebing Feng, Ning Zhang, LianWang, Biao Xu. Reversal of cardiac remodeling after treatment of IgG4 related cholangitis.International Journal of Cardiology, 2016,222:257259.

  58. Zhonghai Wei, Xinlin Zhang, Han Wu, Jun Xie, Qing Dai,Lian Wang, Biao Xu. A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion inpatients with nonvalvular atrial fibrillation.Medicine, 2016,95(31):e4382

  59.  Geng J, Ye X, Liu C, Xie J, Chen J, Xu B, Wang B.Outcomes of off- and on-hours admission in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A retrospective observational cohort study. Medicine (Baltimore). 2016 Jul;95(27):e4093. doi: 10.1097.

  60. Sun JXie JKang LFerro ADong LXu B.Amlodipine Ameliorates Ischemia-Induced Neovascularization in Diabetic Rats through Endothelial Progenitor Cell Mobilization. Biomed Res Int. 2016;2016:3182764. doi: 10.1155/2016/3182764.

  61. Jiang CZhu WShao QYan XJin BZhang MXu B.Tanshinone IIA Protects Against Folic Acid-Induced Acute Kidney Injury..Am J Chin Med2016;44(4):737-53.

  62.   Han Wu, Liang Chen, Jun Xie, Ran Li, Guan-nan Li, Qin-Hua Chen, Xin-Lin Zhang, Li-Na Kang and Biao Xu.Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension. Mol Med Rep. 14: 776-782, 2016.

  63.  Li J, Li Y, Xu B, Jia G, Guo T, Wang D, Xu K, Deng J, Han Y.Short-term rosuvastatin therapy prevents contrast-induced acute kidney injury in female patients with diabetes and chronic kidney disease: a subgroup analysis of the TRACK-D study. J Thorac Dis. 2016 May;8(5):1000-6. doi: 10.21037/jtd.2016.03.26.

  64. Zhonghai Wei, Lian Wang, Jun Xie, Wei Huang, Lina Kang, Kun Wang, Jingmei Zhang, Jie Song, Biao Xu.The therapeutic effect of rotational atherectomy with implantation of drug eluting stent in heavily coronary calcified patients. Journal of Geriatric Cardiology,2016,13:233-238

  65.  Xin-Lin Zhang,Li Zhu,Zhong-HaiWei, Qing-Qing Zhu,Jian-Zhong Qiao, Qing Dai, Wei Huang, Xiao-Hong Li, Jun Xie, Li-Na Kang, LianWang, and Biao Xu.Comparative Efficacy and Safety of Everolimus-Eluting ioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents. Annals of Internal Medicine. 2016 Jun 7;164(11):752-63. doi: 10.7326/M16-0006.

  66. Li RXie JWu HLi GChen JChen QWang LXu B. Syndecan-4 shedding impairs macrovascular angiogenesis in diabetes mellitus. Biochem Biophys Res Commun. 2016 May 20;474(1):15-21. doi: 10.1016/j.bbrc.2016.03.112.

  67.  Guixin He,Wei Tan, BingjianWang, Jianzhou Chen, Guannan Li, Suhui Zhu,Jun Xie, Biao Xu.Increased M1 Macrophages Infiltration Is Associated with Thrombogenesis in Rheumatic Mitral Stenosis Patients with Atrial Fibrillation.PloS One. 2016 Mar 1;11(3):e0149910. doi: 10.1371/journal.pone.0149910.

  68.  Qiaoling Li, Jun Xie, BingjianWang, Ran Li, Jian Bai, Liang Ding, Rong Gu,LianWang, Biao Xu.Overexpression of microRNA-99a Attenuates Cardiac ypertrophy. PLoS One. 2016 Feb 25;11(2):e0148480.


承擔科研項目[項目負責人]

2020年,基于抗炎策略的間充質幹細胞外泌體治療急性心梗心肌缺血再灌注損傷的研究,國家自然科學基金-面上項目,82070366

2017年,江蘇省醫學重點學科,江蘇省衛生和計劃生育委員會

2016年,經皮梗死血管綜合血栓清除治療急性心梗的臨床研究,江蘇省科技廳社會發展項目(重大項目)BE2016607

2015年,PAK3在心肌肥大中的作用和機制研究,國家自然基金面上項目,81470371

2014年,心肌細胞再生的基礎和應用研究,南大伟德官网手机版省分子醫學重點實驗室

2013年,南京心血管病臨床醫學中心,南京市衛生和計劃生育委員會

2013年,Cdx2+胎盤幹細胞移植治療急性心肌梗塞的實驗研究,國家自然科學基金面上項目,81270281

2012年,急性心肌梗死的規範化診治的流程和新技術的建立及應用,江蘇省臨床醫學科技專項,BL2012014

2011年,轉ILK基因治療終末期心髒病,江蘇省衛生廳醫學領軍人才和領軍團隊,LJ201153

2011年,轉ILK基因治療終末期心髒病的基礎研究,南大中央高校重點項目,1114021402

2010年,心肌高表達ILK對心力衰竭心功能的影響及其機制研究,國家自然科學基金面上項目,81070195

2009年,移植轉染ILK基因的幹細胞治療急性心梗療效和機制研究,省科技廳自然基金,BK2009036

2008年,糖尿病組織缺血後血管新生障礙的基礎和臨床研究,科技局國際合作,200801121

2007年,糖尿病血管新生障礙的基礎和臨床研究,衛生廳興衛工程,RC2007001

2006年,心髒幹細胞的基礎和臨床研究,人事廳六大人才高峰項目

2006年,心髒幹細胞的基礎和臨床研究,科技局社會發展,200601057

2004年,糖尿病動脈粥樣硬化斑塊不穩定性增加的分子機制,省科技廳自然基金,BK2004083

2003年,急性心肌梗塞血管内超聲消融的基礎和臨床研究,衛生局重點項目,ZKX0316

獲獎情況

新一代準分子激光經皮冠脈斑塊消蝕術(2020年,江蘇省醫學新技術一等獎,排名第一)

新一代準分子激光經皮冠脈斑塊消蝕術(2019南京市衛生與健康新技術特等獎,排名第一)

心力衰竭發生發展的分子靶點探索和應用基礎研究(2019年江蘇省科技進步二等獎,排名第一))。

利用系統評價及荟萃分析方法探索并解決心血管介入及藥物治療臨床問題(2019年,江蘇醫學科技一等獎,排名第一)。

左室重構的分子機制和幹預靶點的研究(2018年,中華醫學科技獎三等獎,排名第一)

左室重構的分子機制和幹預靶點的研究(2017年,江蘇省醫學科技獎一等獎 ,排名第一)。

主動脈内球囊反搏支持下聯合血管内超聲指導行左主幹鈣化病變旋磨及藥物支架植入術(2017年,江蘇省醫學新技術一等獎,排名第一)。

促進EPC動員治療心肌梗死的臨床新技術應用(2014年,江蘇省醫學新技術引進一等獎,排名第一)。

糖尿病血管功能障礙的基礎及臨床研究(2013年,江蘇醫學科技獎一等獎,排名第一)。

糖尿病血管功能障礙的基礎及臨床研究(2013年,江蘇省科技進步獎三等獎,排名第一)。

糖尿病血管功能障礙的基礎及臨床研究(2013年,南京市科技進步獎二等獎,排名第一)。



Baidu
sogou